Biblio Discovery — Demo Discovery Service

18 results for "Azadeh Zolfaghari"

Showing 1–18 · 1.14 seconds · RSS

  1. Journal Article Full text

    Development of a scoring system using a statistical model to predict cure status in patients with cutaneous leishmaniasis

    Khoshhali, Mehri; Hosseini, Sayed Mohsen; Nilforoushzadeh, Mohammad Ali et al.

    J Res Med Sci · 2017 · English · PubMed Central

    BACKGROUND: The present study was performed to develop a scoring system for predicting cure status in patients with cutaneous leishmaniasis (CL). MATERIALS AND METHODS: This study included 199 patients with CL from Skin Diseases and Leishmaniasis Research Center (Isfahan, Iran). Data were collected…

    Also available at: DOAJ

  2. Journal Article Full text

    Clinical and Epidemiological Characteristics of Leishmania Species in Isfahan, Iran

    Azadeh Zolfaghari; Keivan Beheshti-Maal; Ali Mohammad Ahadi et al.

    Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, Vol. 18 No. 1 · 2024 · Persian · DOAJ

    Background and Objectives: Leishmaniasis is a vector-borne disease that caused by kinetoplastid protozoa of the Leishmania genus. This study aims to investigate the clinical and epidemiologic characteristics of Leishmania species in patients with cutaneous leishmaniasis (CL) in Isfahan, Iran…

  3. Journal Article

    Leishmania RNA Virus and Its Impact on Drug Response and Clinical Outcomes in Leishmaniasis: A Comprehensive Review

    Azadeh Zolfaghari; Sarah Seyedyousefi; Zabihollah Shahmoradi et al.

    Journal of Parasitology Research, Vol. 2026 · 2026 · English · DOAJ Scopus

    Leishmania RNA viruses (LRVs) have emerged as significant modulators of disease severity, therapeutic response, and clinical outcomes in various forms of leishmaniasis. This review provides a comprehensive overview of the current knowledge surrounding LRV1 and LRV2, focusing on their taxonomy…

  4. Journal Article

    The Efficacy of an Innovative Method of Melanocytes-Keratinocytes Suspension for the Treatment of Stable Vitiligo (A Report of 20 Cases)

    Fariba Jaffary; Mohammad Ali Nilforoushzadeh; Elaheh Haftbaradaran et al.

    مجله دانشکده پزشکی اصفهان, Vol. 34 No. 370 · 2016 · Persian · DOAJ Scopus

    Background: Vitiligo is the most common chronic depigmentation disorder caused by melanocyte loss in the basal epidermis. Drug therapy and surgical procedures are two main modalities for its treatment and one of the most effective surgical procedures is non-cultured epidermal cell transplantation…

  5. Journal Article

    Comparing Eyebrow Hair Transplantation Success Rate in Patients with and without Eyebrow Tattoo

    Mohammad Ali Nilforoushzadeh; Elaheh Haftbaradaran; Masoud Baghaei et al.

    مجله دانشکده پزشکی اصفهان, Vol. 34 No. 372 · 2016 · Persian · DOAJ Scopus

    Background: Hair loss can occur due to many diseases and is usually related to treatment of an underlying cause. However, eyebrow may not grow back and restoration with methods such as tattoos or hair transplant surgery is needed. The aim of this study was to determine the impact of tattooing on…

  6. Journal Article

    Comparing the Improvement of Unstable Vitiligo in Patients Treated by Topical PUVA-Therapy Alone, Topical PUVA-Therapy and Oral Vitamin D, and Topical PUVA-Therapy and Oral Vitamin D and Vitamin B12

    Fariba Iraji; Elaheh Haftbaradaran; Somayeh Davashi et al.

    مجله دانشکده پزشکی اصفهان, Vol. 34 No. 416 · 2017 · Persian · DOAJ Scopus

    Background: Vitiligo is an acquired multifactorial disorder. Different treatments are used for it and all of them have adverse side-effects. Vitiligo is an autoimmune disease associated with other autoimmune diseases such as hypothyroidism, hyperthyroidism, rheumatoid arthritis, diabetes mellitus…

  7. Journal Article

    Heat therapy for cutaneous leishmaniasis: A literature Review

    Amir Hossein Siadat; Fariba Iraji; Azadeh Zolfaghari et al.

    Journal of Research in Medical Sciences, Vol. 26 No. 1 · 2021 · English · DOAJ Scopus

    Cutaneous leishmaniasis (CL) is endemic in many parts of the world with a high economic and health impact. Despite many treatments that have been suggested for this zoonotic infection, there is still no definite therapy for CL. Meglumine antimony compounds are considered as a standard treatment for…

  8. Journal Article

    Treatment of cutaneous leishmaniasis with intense pulsed light: Is it effective?

    Amirhossein Siadat; Hamid Galehdari; Zabiholah Shahmoradi et al.

    Advanced Biomedical Research, Vol. 12 No. 1 · 2023 · English · DOAJ Scopus

    Background: Cutaneous leishmaniasis (CL) is a common parasitic disorder that is endemic in many countries. There is no completely effective treatment for this condition, but pentavalent antimony compounds are regarded as the main treatment. Different laser types have been used for treatment of CL…

  9. Journal Article

    Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review

    Parisa Mousavi; Azadeh Zolfaghari; Maryam Aghaei et al.

    Advanced Biomedical Research, Vol. 14 No. 1 · 2025 · English · DOAJ Scopus

    The obligate intracellular parasite, Leishmania, causes leishmaniasis as an infectious disease. The parasite is transmitted through female sandfly bites and infects the host mononuclear phagocytes, leading to severe skin lesions and fatal systemic infection. The quick diagnosis and effective…

  10. Journal Article

    Dermatology case diagnosis

    Amir Hossein Siadat; Neda Adibi; Mohhamad Ali NilfroushZadeh et al.

    Journal of Research in Medical Sciences, Vol. 12 No. 4 · 2007 · English · DOAJ Scopus

    A patient with multiple subcutaneous mobile lesions limited to forearms is presented. Pathologic review of the biopsy confirmed the diagnosis.

  11. Journal Article

    Genetic Diversity and Chromosomal Variations in the Iranian Leishmania major Strain: Insights into Pathogenicity and Drug Resistance

    Hanieh Sharifian; Anis Khalafiyan; Mahmood Fadaie et al.

    Advanced Biomedical Research, Vol. 14 No. 1 · 2025 · English · DOAJ Scopus

    Background: Leishmaniasis is a major public health concern, with a high annual incidence and extensive geographical distribution. This parasitic disease is transmitted through the bite of specific species of sand flies and is caused by flagellated protozoa. Leishmania major is one of the main…

  12. Journal Article

    Frequency and Correlation of Peripheral and Tissue Eosinophilia With Clinical Manifestations in Patients With Bullous Pemphigoid

    Bahareh Abtahi-Naeini; Farhad Zare-Mehrjerdi; Zabihollah Shahmoradi et al.

    Dermatology Practical & Conceptual, Vol. 14 No. 3 · 2024 · English · DOAJ Scopus

    Introduction: Bullous pemphigoid (BP) is an autoimmune disease involving the sub-epidermal layer. Eosinophilia may play a role in the pathogenesis of BP. Objectives: We aimed to investigate the correlation between dermal or peripheral eosinophilia with clinical presentations in patients with BP…

  13. Journal Article Full text

    Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice

    Mohammad Ali Nilforoushzadeh , Leila Shirani-Bidabadi , Azadeh Zolfaghari-Baghbaderani , Reza Jafari , Motahar Heidari-Beni , Amir Hossein Siadat & Mehdi Ghahraman-Tabrizi

    Journal of Vector Borne Diseases, Vol. 49 No. 4 · 2012 · English · DOAJ Scopus

    Background & objectives: Cutaneous leishmaniasis is an infection caused by protozoan genus Leishmania. Althoughglucantime is commonly used for the treatment of leishmaniasis, it has some side effects including increased liverenzymes and electrocardiogram changes. In addition, the drug is expensive…

  14. Journal Article

    Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Mice (Balb/c)

    Mohammad Ali Nilforoushzadeh; Leila Shirani Bidabadi; Reza Jafary et al.

    مجله دانشکده پزشکی اصفهان, Vol. 29 No. 158 · 2011 · Persian · DOAJ Scopus

    Background: Cutaneous leishmaniasis is an infection caused by protozoan genus leishmania the incidence rate of which has been estimated as 0.28 in every 1000 individuals in Iran. Although glucantime is commonly used to treat leishmaniasis, it has some side effects including increased liver enzymes…

  15. Journal Article

    In vitro and in vivo evaluation of the leishmanicidal and cytotoxic activities of chitosan and chitosan–amphotericin B

    Parisa Mousavi; Bahman Rahimi Esboei; Maryam Pourhajibagher et al.

    AMB Express, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Cutaneous leishmaniasis (CL), classified as a neglected tropical disease (NTD), is a significant public health concern caused by Leishmania protozoa. It is transmitted through the bites of infected female sandflies and manifests in various forms, ranging from localized skin ulcers to…

  16. Journal Article

    Demographic characteristics of the patients with cutaneous vasculitis due to COVID-19 infection

    Fariba Iraji; Fatemeh Mokhtari; Azadeh Zolfaghari et al.

    Indian Journal of Dermatology, Vol. 67 No. 4 · 2022 · English · DOAJ Scopus

    Background: Cutaneous manifestations of coronavirus disease 2019 (COVID-19) range from mild skin rashes to severe vasculitis. In the current study, we evaluated the demographic characteristics of the patients with cutaneous vasculitis following COVID-19 infection. Materials and Methods: In the…